14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.260 68 days ( -180.36 % )
Last Price $1.57 -5.99 %
High/ Low $1.55 - $1.74 27.74%
Chg 7 Days 18.94 % $1.32 $1.57
Chg 30 Days 50.96 % $1.04 $1.57
Chg 12 mos 98.16 % $0.792 $1.57
Trend - 3 mos 143.74 % Width: 30.80 %
Trend - 12 mos 36.77 % Width: 171.35 %
Pred. range - 3 mos $3.14 - $4.11 100.11 % - 161.75 %
Pred. range - 12 mos $0.84 - $2.29 -46.33 % - 45.64 %
Short MA avg 3 mos Buy Apr 26, 2024 - 6 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jan 26, 2024 - 69 days
Long MA avg 12 mos Buy Jan 26, 2024 - 69 days
Short/Long MA avg 12 mos Buy Jan 23, 2024 - 72 days
Pivot Short Sell May 02, 2024 - 2 days
Bollinger Buy Apr 03, 2024 - 23 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Nektar Therapeutics

Nektar Therapeutics Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a... NKTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT